Annual Working Capital
$19.34 M
-$1.04 M-5.12%
31 December 2023
Summary:
Sunshine Biopharma annual working capital is currently $19.34 million, with the most recent change of -$1.04 million (-5.12%) on 31 December 2023. During the last 3 years, it has risen by +$19.36 million (+76348.79%). SBFMW annual working capital is now -5.12% below its all-time high of $20.38 million, reached on 31 December 2022.SBFMW Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$21.45 M
+$1.00 M+4.91%
30 September 2024
Summary:
Sunshine Biopharma quarterly working capital is currently $21.45 million, with the most recent change of +$1.00 million (+4.91%) on 30 September 2024. Over the past year, it has increased by +$1.11 million (+5.44%). SBFMW quarterly working capital is now -48.78% below its all-time high of $41.88 million, reached on 30 June 2022.SBFMW Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.1% | +5.4% |
| 3 y3 years | +10000.0% | +962.0% |
| 5 y5 years | +2858.8% | +2855.0% |
SBFMW Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.1% | >+9999.0% | -48.8% | +962.0% |
| 5 y | 5 years | -5.1% | +2618.5% | -48.8% | +2855.0% |
| alltime | all time | -5.1% | +1689.8% | -48.8% | +1863.7% |
Sunshine Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.45 M(+4.9%) |
| June 2024 | - | $20.45 M(-8.3%) |
| Mar 2024 | - | $22.30 M(+15.3%) |
| Dec 2023 | $19.34 M(-5.1%) | $19.34 M(-5.0%) |
| Sept 2023 | - | $20.35 M(-5.1%) |
| June 2023 | - | $21.44 M(+18.8%) |
| Mar 2023 | - | $18.04 M(-11.5%) |
| Dec 2022 | $20.38 M(+868.4%) | $20.38 M(-49.5%) |
| Sept 2022 | - | $40.38 M(-3.6%) |
| June 2022 | - | $41.88 M(+214.7%) |
| Mar 2022 | - | $13.31 M(+532.4%) |
| Dec 2021 | $2.10 M(-8398.2%) | $2.10 M(+4.2%) |
| Sept 2021 | - | $2.02 M(+72.9%) |
| June 2021 | - | $1.17 M(+19.5%) |
| Mar 2021 | - | $977.05 K(-3952.4%) |
| Dec 2020 | -$25.36 K(-96.7%) | -$25.36 K(-88.5%) |
| Sept 2020 | - | -$220.24 K(-61.6%) |
| June 2020 | - | -$574.03 K(-22.2%) |
| Mar 2020 | - | -$738.27 K(-3.9%) |
| Dec 2019 | -$767.84 K(+9.5%) | -$767.84 K(-1.4%) |
| Sept 2019 | - | -$778.70 K(-8.9%) |
| June 2019 | - | -$854.83 K(-3.8%) |
| Mar 2019 | - | -$888.44 K(+26.7%) |
| Dec 2018 | -$700.97 K(+10.6%) | -$700.97 K(+17.5%) |
| Sept 2018 | - | -$596.64 K(-36.5%) |
| June 2018 | - | -$940.05 K(-3.9%) |
| Mar 2018 | - | -$978.51 K(+54.4%) |
| Dec 2017 | -$633.94 K(+194.0%) | -$633.94 K(+53.9%) |
| Sept 2017 | - | -$411.96 K(-36.0%) |
| June 2017 | - | -$643.32 K(+141.4%) |
| Mar 2017 | - | -$266.46 K(+23.6%) |
| Dec 2016 | -$215.64 K(-82.3%) | -$215.64 K(-15.1%) |
| Sept 2016 | - | -$253.88 K(-77.7%) |
| June 2016 | - | -$1.14 M(+18.8%) |
| Mar 2016 | - | -$959.50 K(-21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -$1.22 M(+213.8%) | -$1.22 M(+265.4%) |
| Sept 2015 | - | -$332.93 K(+25.5%) |
| June 2015 | - | -$265.32 K(+15.1%) |
| Mar 2015 | - | -$230.53 K(-40.5%) |
| Dec 2014 | -$387.58 K(+4927.0%) | -$387.58 K(+40.2%) |
| Sept 2014 | - | -$276.36 K(-18.3%) |
| June 2014 | - | -$338.22 K(+198.7%) |
| Mar 2014 | - | -$113.23 K(+1368.6%) |
| Dec 2013 | -$7710.00(-110.9%) | -$7710.00(-116.0%) |
| Sept 2013 | - | $48.08 K(-67.1%) |
| June 2013 | - | $146.13 K(-38.2%) |
| Mar 2013 | - | $236.60 K(+236.0%) |
| Dec 2012 | $70.43 K(-31.6%) | $70.43 K(-72.2%) |
| Sept 2012 | - | $253.19 K(+218.1%) |
| June 2012 | - | $79.59 K(+25.0%) |
| Mar 2012 | - | $63.66 K(-38.2%) |
| Dec 2011 | $103.00 K(-47.5%) | $103.00 K(-53.1%) |
| Sept 2011 | - | $219.67 K(+54.1%) |
| June 2011 | - | $142.51 K(-10.4%) |
| Mar 2011 | - | $159.00 K(-19.0%) |
| Dec 2010 | $196.22 K(+100.6%) | $196.22 K(+132.6%) |
| Sept 2010 | - | $84.37 K(<-9900.0%) |
| June 2010 | - | -$407.00(-103.1%) |
| Mar 2010 | - | $13.15 K(-92.7%) |
| Dec 2009 | $97.80 K(-652.2%) | - |
| Oct 2009 | - | $179.84 K(-520.9%) |
| July 2009 | - | -$42.73 K(+25.8%) |
| Apr 2009 | - | -$33.96 K(+20.9%) |
| Jan 2009 | - | -$28.08 K(+15.6%) |
| Oct 2008 | - | -$24.29 K(+37.1%) |
| July 2008 | -$17.71 K(-232.2%) | -$17.71 K(+46.6%) |
| Apr 2008 | - | -$12.08 K(-615.8%) |
| Jan 2008 | - | $2342.00(-49.2%) |
| Oct 2007 | - | $4607.00 |
| July 2007 | $13.39 K | - |
FAQ
- What is Sunshine Biopharma annual working capital?
- What is the all time high annual working capital for Sunshine Biopharma?
- What is Sunshine Biopharma annual working capital year-on-year change?
- What is Sunshine Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly working capital year-on-year change?
What is Sunshine Biopharma annual working capital?
The current annual working capital of SBFMW is $19.34 M
What is the all time high annual working capital for Sunshine Biopharma?
Sunshine Biopharma all-time high annual working capital is $20.38 M
What is Sunshine Biopharma annual working capital year-on-year change?
Over the past year, SBFMW annual working capital has changed by -$1.04 M (-5.12%)
What is Sunshine Biopharma quarterly working capital?
The current quarterly working capital of SBFMW is $21.45 M
What is the all time high quarterly working capital for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly working capital is $41.88 M
What is Sunshine Biopharma quarterly working capital year-on-year change?
Over the past year, SBFMW quarterly working capital has changed by +$1.11 M (+5.44%)